Tchernev Georgi
Department of Dermatology and Venerology, Trakian University, Medical Faculty, Stara Zagora, Bulgaria.
Indian J Dermatol. 2011 May;56(3):318-20. doi: 10.4103/0019-5154.82492.
Folliculitis et perifolliculitis capitis abscedens et suffodiens is a rare disease of unknown etiology. It is a suppurative process that involves the scalp, eventually resulting in extensive scarring and irreversible alopecia. The condition is also known as 'acne necrotica miliaris' or 'Proprionibacterium' folliculitis. Most often the disease affects men of African-American or African-Caribbean descent between 20 and 40 years of age. The clinical picture is determined by fluctuating painful fistule-forming conglomerates of abscesses in the region of the occipital scalp. The cause of scalp folliculitis is not well understood. It is generally considered to be an inflammatory reaction to components of the hair follicle, particularly the micro-organisms. These include: bacteria (especially Propionibacterium acnes, but in severe cases, also Staphylococcus aureus), Yeasts (Malassezia species) and mites (Demodex folliculorum). The initial histopathologic finding is an exclusively neutrophilic infiltration followed by a granulomatous infiltrate. The treatment of the disease is usually difficult and often disappointing. Successful treatment with isotretinoin 1 mg/kg body mass could be achieved only after regular systematic administration in the course of 3-4 months. Here we describe a patient with eruptive purulent form of the disease, which has been controlled with combination therapy: systemic antibiosis with metronidazole and clindamycin, dermatosurgical removal of single nodular formations, and isotretinoin 1 mg/kg body mass for 3-5 months.
穿掘性毛囊周围炎是一种病因不明的罕见疾病。它是一种化脓性过程,累及头皮,最终导致广泛瘢痕形成和不可逆性脱发。该病症也被称为“粟粒性坏死性痤疮”或“丙酸杆菌性”毛囊炎。该病最常影响年龄在20至40岁之间的非裔美国或非裔加勒比裔男性。临床表现为枕部头皮区域出现波动的、疼痛性的、形成瘘管的脓肿团块。头皮毛囊炎的病因尚不完全清楚。一般认为它是对毛囊成分,特别是微生物的一种炎症反应。这些微生物包括:细菌(尤其是痤疮丙酸杆菌,但在严重病例中也有金黄色葡萄球菌)、酵母菌(马拉色菌属)和螨虫(毛囊蠕形螨)。最初的组织病理学发现是单纯的中性粒细胞浸润,随后是肉芽肿性浸润。该病的治疗通常困难且往往令人失望。仅在3至4个月期间定期系统给药后,使用异维A酸1毫克/千克体重才能成功治疗。在此,我们描述了一名患有该病爆发性化脓形式的患者,其病情已通过联合治疗得到控制:使用甲硝唑和克林霉素进行全身抗菌治疗、通过皮肤外科手术切除单个结节性病变,以及使用异维A酸1毫克/千克体重治疗3至5个月。